NCT05870501View on ClinicalTrials.gov

Synaptic Imaging and Network Activity in Treatment Resistant Depression

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

September 13, 2023

Study Completion Date

September 13, 2023

Conditions
Depressive DisorderDepressive Disorder, MajorDepressive Disorder, Treatment-ResistantBipolar DisorderBipolar Disorder IBipolar Disorder IIMood DisordersAnhedonia
Interventions
DRUG

Ketamine

0.5mg/kg IV infusion

DRUG

Midazolam

0.045mg/kg IV infusion

Trial Locations (1)

SE5 8AF

The Institute of Psychiatry, Psychology & Neuroscience, King's College London, London

All Listed Sponsors
collaborator

South London and Maudsley NHS Foundation Trust

OTHER

lead

King's College London

OTHER

NCT05870501 - Synaptic Imaging and Network Activity in Treatment Resistant Depression | Biotech Hunter | Biotech Hunter